Skip to main content
SpringerLink
Log in

Efficacy in behavioural models of antidepressant activity

  • Chapter
St. John’s Wort and its Active Principles in Depression and Anxiety

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

  • 989 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Müller WE (2003) Current St. John’s Wort research from mode of action to clinical efficacy. Pharmacol Res 47: 101–109

    Article  PubMed  Google Scholar 

  2. Gambarana C, Ghiglieri O, Tolu P, De Montis MG, Giachetti D, Bombardelli E, Tagliamonte A (1999) Efficacy of an Hypericum perforatum (St. John’s Wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacol 21: 247–257

    Article  Google Scholar 

  3. Butterweck V, Wall A, Liefländer-Wulf U, Winterhoff H, Nahrstedt A (1997) Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30(Suppl): 117–124

    PubMed  Google Scholar 

  4. Bhattacharya S-K, Chakrabarti A, Chatterjee SS (1998) Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models. Pharmacopsychiatry 31(Suppl 2): 22–29

    PubMed  Google Scholar 

  5. Cervo L, Rozio M, Ekalle-Soppo CB, Guiso G, Morazzoni P, Caccia S (2002) Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology 164: 423–428

    Article  PubMed  Google Scholar 

  6. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 63: 499–510

    Article  PubMed  Google Scholar 

  7. Gambarana C, Tolu P, Masi F, Rinaldi M, Giachetti D, Morazzoni P, De Montis MG (2001) A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry 34(Suppl): 42–44

    Article  Google Scholar 

  8. Usai M, Leggio B, Grappi S, Nanni G, Gambarana C, Tolu P, Giachetti D, De Montis MG (2003) Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum. Pharmacopsychiatry 36: 283–287

    Article  PubMed  Google Scholar 

  9. Butterweck V, Petereit F, Whinterhoff H, Nahrstedt A (1998) Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med 64: 291–294

    PubMed  Google Scholar 

  10. Butterweck V, Korte B, Winterhoff H (2001) Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 34(Suppl): 2–7

    Article  Google Scholar 

  11. Erdelmeier CAJ (1998) Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychiatry 31(Suppl): 2–6

    PubMed  Google Scholar 

  12. Nöldner M, Schötz K (2002) Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 68: 577–580

    Article  PubMed  Google Scholar 

  13. Willner P (1990) Animal models of depression: an overview. Pharmacol Ther 45: 425–455

    Article  PubMed  Google Scholar 

  14. Willner P (1991) Animal models as simulations of depression. Trends Pharmacol Sci 12: 131–136

    Article  PubMed  Google Scholar 

  15. Willner P (1995) Animal models of depression: validity and applications. Adv Biochem Psychopharmacol 49: 19–41

    PubMed  Google Scholar 

  16. Dhawan KN, Jaju BP, Gupta GP (1970) Validity of antagonism of different effects of reserpine as test for anti-depressant activity. Psychopharmacologia 18: 94–98

    PubMed  Google Scholar 

  17. Bourin M (1990) Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fundam Clin Pharmacol 4: 49–64

    PubMed  Google Scholar 

  18. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85: 367–370

    PubMed  Google Scholar 

  19. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, Simon P, Porsolt RD (1987) The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 11: 659–671

    PubMed  Google Scholar 

  20. Porsolt RD, LePichon R, Jalfre R (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730–732

    PubMed  Google Scholar 

  21. Overmier JB, Seligman MEP (1967) Effects of inescapable shock upon subsequent escape and avoidance learning. J Comp Physiol Psychol 63: 23–33

    Google Scholar 

  22. Sherman AD, Sacquitine JL, Petty F (1982) Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16: 449–454

    PubMed  Google Scholar 

  23. Gambarana C, Scheggi S, Tagliamonte A, Tolu P, De Montis MG (2001) Animal models for the study of antidepressant activity. Brain Res Prot 7: 11–20

    Google Scholar 

  24. Meloni D, Gambarana C, De Montis MG, Dal Prà P, Taddei I, Tagliamonte A (1993) Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats, Pharmacol Biochem Behav 46: 423–426

    PubMed  Google Scholar 

  25. Papp M, Moryl E, Willner P (1996) Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296: 129–136

    PubMed  Google Scholar 

  26. Papp M, Willner P, Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104: 255–259

    PubMed  Google Scholar 

  27. Ghiglieri O, Gambarana C, Scheggi S, Tagliamonte A, Willner P, De Montis MG (1997) Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav Pharmacol 8: 619–628

    PubMed  Google Scholar 

  28. Guilhermano LG, Ortiz L, Ferigolo M, Barros HMT (2004) Commercially available Hypericum perforatum extracts do not decrease immobility of rats in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 28: 49–55

    PubMed  Google Scholar 

  29. Öztürk Y (1997) Testing the antidepressant effects of Hypericum species on animal models. Pharmacopsychiatry 30(Suppl): 125–128

    Google Scholar 

  30. De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch KR (1999) Comparison of Hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur Neuropsychopharmacol 9: 461–468

    Article  PubMed  Google Scholar 

  31. Öztürk Y, Aydin S, Beis R, Baser KHC, Berberoglu H (1995) Effects of Hypericum perforatum L. and Hypericum calycinium L. extracts on the central nervous system in mice. Pythomedicine 3: 137–144

    Google Scholar 

  32. Chatterjee SS, Nöldner M, Koch E, Erdelmeier C (1998) Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry (Suppl) 31: 7–15

    PubMed  Google Scholar 

  33. Gambarana C, Grappi S, Nanni G (2001) Dose-dependent antidepressant activity of hyperforin in rats. Soc Neurosci Abstr 27: 975.12

    Google Scholar 

  34. Rezvani AH, Overstreet DH, Yang Y, Clark E Jr, (1999) Attenuation of alcohol intake by extract of Hypericum perforatum (St. John’s Wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol 34: 699–705

    PubMed  Google Scholar 

  35. Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Massi M (2000) Effects of Hypericum perforatum extract on ethanol intake, and on behavioral despair: A search for the neurochemical systems involved. Pharmacol Biochem Behav 66: 105–111

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Pharmacology Unit, University of Siena, Via Moro 4, 53100, Siena, Italy

    Carla Gambarana

  2. Department of Environmental Sciences, University of Siena, 53100, Siena, Italy

    Daniela Giachetti

Authors
  1. Carla Gambarana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Giachetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut für Naturwissenschaftler, Biozentrum Universität Frankfurt, Marie-Curie-Str.9, 60439, Frankfurt, Germany

    Walter E. Müller

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Gambarana, C., Giachetti, D. (2005). Efficacy in behavioural models of antidepressant activity. In: Müller, W.E. (eds) St. John’s Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7338-5_6

Download citation

Publish with us

Policies and ethics

Search

Navigation